Cochrane News

Subscribe to Cochrane News feed
Updated: 11 hours 9 min ago

Effectiveness of paracetamol as a treatment for acute or chronic pain conditions

Tue, 11/08/2016 - 10:49

Low back pain (LBP) is a common condition, widely reported as a major health and socioeconomic problem associated with work absenteeism, disability, and high costs for patients and society. Paracetamol is widely recommended for a variety of acute and chronic pain conditions, but a Cochrane Review published in June 2016 called its effectiveness into question.

Related resources and media coverage

Paracetamol for low back pain

"Paracetamol: widely used and largely ineffective", Evidently Cochrane

"What's the point of paracetemol?", The Conversation

"Paracetamol is often ‘NO better than placebo – only easing headaches for 1 in 10 of us’", The Sun

"Should YOU be taking paracetamol? Expert claims the common painkiller is 'often no better than a placebo'", Daily Mail

"What’s the point of paracetamol?", Sydney Morning Herald

"What should I take paracetamol for?", The Guardian Online Life and Style Blog

 

 

Monday, November 14, 2016

The Cochrane Community responds to Strategy to 2020

Mon, 11/07/2016 - 13:27

Cochrane's Strategy to 2020 aims to put Cochrane evidence at the heart of health decision-making all over the world. It defines how we intend to accomplish this and provides a framework for Cochrane’s future decision-making, helping us respond to the strategic opportunities and challenges that we face in the next decade and beyond. It is the result of a collaborative process undertaken by our global network of contributors; and represents the collective vision of the organization to 2020 that relies on those contributors to ensure its success.

Cochrane's 2016 Annual General Meeting, held in Seoul during our annual Colloquium, included a Special Session where the Cochrane Community had the opportunity to share their stories of responding to the challenges of Strategy to 2020. As well as live presentations from a selection of Cochrane Groups from around the world, the session included this video highlighting just a few stories among many of what Strategy to 2020 means to Cochrane Groups and their work within local contexts.

Monday, November 7, 2016 Category: Making a Difference

Cochrane seeks Financial Controller - London, UK

Fri, 11/04/2016 - 19:08

 Salary: Competitive (22.5-30 hours per week)
 Location: London, Greater London
 Job Type: Part-time
Application closing date:
25 November 2016
 
Cochrane is a global independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making the vast amounts of evidence generated through research useful for informing decisions about health. We do this by identifying, appraising and synthesizing individual research findings to produce the best available evidence on what can work, what might harm and where more research is needed.

Our work is recognised as the international gold standard for high quality, trusted information. We want to be the leading advocate for evidence-informed health care across the world.

The Role:
We are currently looking for a part-time Financial Controller to support the Head of Finance and Core Services in providing an efficient and effective finance function for Cochrane and Cochrane Innovations.

Required skills:
Essential

  • Qualified accountant
  • Good all round knowledge of current accounting practice, the charity SORP, VAT, the requirements of charity taxation and charity and company legislation.
  • Experience of using Xero
  • Experience of foreign currency transactions
  • Advanced Microsoft Excel skills
  • Ability to prioritise multiple tasks within a project using project management skills
  • Experience of working in cross functional teams
  • Excellent communication skills with the ability to build relationships across the business
  • Have the proven ability to work both independently and as part of a team
  • Ability to accomplish projects with little supervision
  • Ability to work to tight deadlines
  • Can demonstrate strong problem solving skills and think widely and deeply when faced with new problems
  • Relevant experience of preparing management accounts and budgets
  • Proven experience of funder reports and audit files
  • Experience of costing models and accurate budgets relating to bids for new funding
  • Proven experience of building productive working relationships, both internally and externally in an international environment
  • Ability to communicate clearly with non-finance employees about financial matters, and to deliver effective finance training where necessary
  • Awareness of agile/remote working
  • Commitment to Cochrane’s mission and values

Desirable

  • Experience of healthcare charity sector

For more information, please see the full job description.

Application:
If you would like to apply for this position, please send a CV in English along with a letter of motivation to recruitment@cochrane.org with “Financial Controller” in the subject line. The letter of motivation should indicate why you are applying for the post, and how far you meet the requirements for the post outlined in the job description using specific examples. List your experience, achievements, knowledge, personal qualities and skills which you feel are relevant to the post.

Friday, November 4, 2016 Category: Jobs

The impact of Cochrane evidence on tranexamic acid for acute traumatic injury

Wed, 11/02/2016 - 23:57

For more than 20 years, Cochrane has produced systematic reviews of primary research in human health care and health policy. We are internationally recognized as the highest standard in evidence-based healthcare resources. The Cochrane Making a Difference series focuses on stories of how Cochrane evidence has made an impact on real-world health decision making and outcomes.

More than four million people worldwide die of injuries every year, often because of extensive blood loss. Antifibrinolytic drugs, including tranexamic acid (TXA), promote blood clotting. The Cochrane Review 'Antifibrinolytic drugs for acute traumatic injury', published in May 2015 from the Cochrane Injuries Group, found evidence that using TXA safely reduces mortality in trauma patients with bleeding without increasing the risk of adverse events.

The review includes high-quality evidence gathered from more than 20,000 patients in 40 countries. As a result of these findings, TXA is now being used as an intervention for traumatic injuries by armed forces and ambulance services around the world, and has been added to the WHO Essential Medicines list.

Review author Ian Roberts tells us more about this important review and its impact on practice:

Thursday, November 3, 2016 Category: Making a Difference

Cochrane in the news: November 2016

Wed, 11/02/2016 - 19:21

A round-up of selected recent coverage citing, discussing, and presenting health evidence - updated throughout the month.

The Last Tuesday Project names Cochrane as ‘one of the most reliable resources of healthcare information’ and a ‘health researcher’s dream’. In their blogpost they explain why they find Cochrane reliable and how to best use Cochrane as a resource.

Struggling to explain why not all health research (or all health news) is equally credible or useful? Vox has created 'The one chart you need to understand any health study' - with systematic reviews and meta-analyses described as 'the king of all evidence' and including a mention of the Cochrane Library.

Tuesday, November 8, 2016

Director of Cochrane South Africa honoured

Tue, 11/01/2016 - 18:48

Jimmy Volmink recognized for his contribution to evidence-based healthcare

The South African Medical Research Council (MRC) called Prof Jimmy Volmink, Director of Cochrane South Africa the African’s regions ‘father of evidence-based healthcare. Volmink, also the Dean of the Faculty of Medicine and Health Sciences at Stellenbosch University was presented with the MRC Recognition Award for “Outstanding Achievements in Contributions to Evidence-based Healthcare in Africa.”

Volmink is the founding Director of the first Cochrane Centre on the African content, Cochrane South Africa, and an internationally acclaimed researcher in health sciences. "His work was underscored by the mission of Cochrane South Africa which stated that health care decision-making on the African continent should be informed by best-available evidence. He has supported many researchers to conduct high-quality research and assisted policymakers in South Africa and the region to build the necessary skills to use research evidence effectively," said MRC in their commendation statement.

Visit the Cochrane South Africa website

Friday, November 11, 2016

Cochrane seeks German translation and dissemination officer - Freiburg, Germany

Wed, 10/26/2016 - 15:30

Specifications: Part-time (50-70%), 12-month fixed-term contract

Location:
Freiburg, Germany preferred

Application closing date:
18 November 2016

About Cochrane
Cochrane is a global independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making the vast amounts of evidence generated through research useful for informing decisions about health. We do this by identifying, appraising, and synthesizing individual research findings to produce the best available evidence on what can work, what might harm and where more research is needed.

Our work is recognized as the international gold standard for high quality, trusted information. We want to be the leading advocate for evidence-informed health care across the world.

The role:
We are looking for a German-language translation and dissemination officer to join our Communications team, preferably based in Freiburg, Germany. Remote working will be considered for the right candidate. This role will be a 50-70% part-time position, for a 12 months fixed term contract.

Required skills:
The successful candidate will be a native German speaker with an excellent command of English. They should be well organized, an excellent communicator, and possess strong attention to detail. We are looking for someone with previous experience in a communications or translations role, ideally with a background in health or science. For more information, please see the full job description.

Application:
If you would like to apply for this position, please send a CV in English along with a letter of motivation to recruitment@cochrane.org with “German translation officer” in the subject line. The letter of motivation should indicate why you are applying for the post, and how far you meet the requirements for the post outlined in the job description using specific examples. List your experience, achievements, knowledge, personal qualities and skills which you feel are relevant to the post.

The deadline for applications is Friday 18 November 2016, and interviews will be held in the week commencing 28 November.

For further information, please contact Juliane Ried, jried@cochrane.org, Translations Co-ordinator.

Wednesday, October 26, 2016 Category: Jobs

Cochrane seeks backend developer and tester (fixed term, 12 weeks) - Western Europe location

Wed, 10/26/2016 - 14:04

Position: fixed-term contract, 12 weeks duration

Location: any Western Europe location considered (Copenhagen, Denmark or Freiburg, Germany, preferred) or location with significant working hours overlap with Western Europe.

Person specification
You are an organised and collaborative developer who will strive for quality and can work independently. You have extensive experience building and testing RESTful web APIs using Java EE and SQL databases, and can quickly familiarize yourself with a complex project and code base.

Essential qualifications

  •  Degree in computer science or related field or equivalent knowledge and experience
  • 2 years’ experience in development and deployment of large-scale web and software applications
  • 5 years’ experience with REST APIs, Java EE, JSON, XML, and SQL databases
  • 2 years’ experience with unit testing, automated test tools, and stress testing
  • Ability to work independently and to a high standard of quality
  • Fluent in English

Preferred

  • Knowledge of Cochrane and systematic reviews
  • Experience using version control software, preferably Git
  • Experience using dependency management tools, e.g. Maven, bower, or npm
  • Willingness to travel as required

Statement of Work
You will be responsible for completing work on Cochrane’s ReviewDB and ensuring that it functions and performs as expected. ReviewDB is Cochrane’s new backend system for managing the content of over 6,000 systematic reviews through the “RevMan” Angular frontend app, as well as the integration point for a number of partner systems. Deliverables:

  1. Complete work on the “round trip” test of our existing reviews from our legacy XML format into ReviewDB and back (week 1).
  2. Extend the permission checking system to allow appropriate access to published versions of reviews. Requires interfacing with our editorial management system, Archie (week 1).
  3. Create an automated test suite for the REST API that covers the key endpoints and use cases for ReviewDB (week 4).
  4. Implement according to specification of a notification system based on WebSockets and the WAMP protocol, so that the RevMan Web client can flag when a resource being viewed has been changed by another user. Apply the same mechanism for cache invalidation, adapting the current eTag system. (week 9)
  5. Create and run stress test scenarios that enable us to assess the performance of ReviewDB and estimate resource needs for the production system, and identify performance hot spots and address key issues where prudent / feasible. (week 12)
  6. Implement request logging. (week 12)

Timelines and reporting structure
The complete work package is expected to be completed in 12 working weeks (60 working days). Work shall start as soon as possible, and completed no later than 24 February 2016.

You will report to Gert van Valkenhoef, Cochrane’ IT Development Manager, who will sign off on deliverables. You will liaise with Cochrane’s development team on technical issues as needed.

About Cochrane
Cochrane is a global independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making the vast amounts of evidence generated through research useful for informing decisions about health. We do this by identifying, appraising and synthesizing individual research findings to produce the best available evidence on what can work, what might harm and where more research is needed.

Our work is recognised as the international gold standard for high quality, trusted information. We want to be the leading advocate for evidence-informed health care across the world.

Applying: If you would like to apply for this position, please send a CV along with a supporting statement to recruitment@cochrane.org with “Backend Developer” in the subject line.  The supporting statement should indicate why you are applying for the post, and how far you meet the requirements for the post outlined in the job description using specific examples.  List your experience, achievements, knowledge, personal qualities and skills which you feel are relevant to the post.

For further information, please  contact Gert van Valkenhoef, gvanvalkenhoef@cochrane.org, IT Development Manager.

Wednesday, October 26, 2016 Category: Jobs

Celebrating the 20th Anniversary of Cochrane Brazil

Mon, 10/24/2016 - 14:19

Established in 1996, this month Cochrane Brazil (Centro Cochrane do Brasil) is celebrating its 20th anniversary. Over the past two decades, Cochrane Brazil has supported authors from different regions of the country, and produced more than 300 Cochrane Reviews for the Brazilian Ministry of Health. Some of these author teams are now in a position to lead the production of Cochrane work in their own regions.

Earlier this year, Cochrane was delighted to announce the launch of its first national Cochrane Network, consisting of the Brazilian Cochrane Centre (located at the Centro de Estudos em Medicina Baseada em Evidências e AvaliaçãoTecnologica em Saúde in São Paulo) and five new Affiliates, located in the cities of Fortaleza and João Pessoa (in the Northeast region of Brazil), in Belém (in the Amazon region), in Petrópolis (in the Southeastern region, near Rio de Janeiro) and in Muriaé (in the Central West region).

To mark their 20th Anniversary celebrations, Dr. Alvaro Atallah, Director of Cochrane Brazil, tells us more about their achievements.


Dr. Alvaro Atallah, how does it feel to be celebrating the 20th anniversary of Cochrane Brazil?
We feel honored for the opportunity to have contributed to the uptake and use of evidence-based health care (EBHC) in many different settings of Brazil. We feel happy with our educational achievements and the training of thousands of Brazilian health professionals, teaching them how to produce and use high-quality synthesized evidence. We feel proud to have contributed with health authorities to help establish national policies regarding evidence-based health care.

 Can you share with us, in your own words, how it all began?
In 1988, Doctors Richard Peto and Rory Collins invited me to help design a randomized trial on aspirin to prevent pre-eclampsia. I went to the Clinical Trials Services Unit in Oxford University where I met Professor Iain Chalmers, with whom I established strong professional and personal bonds which last up to this date. I was invited to participate in the meetings that resulted in the creation of the Cochrane Collaboration in 1992.

Soon after, Iain encouraged us to found the first Cochrane Center in a developing country. Iain was our patron and inaugurated our Centre in October 1996, in Sao Paulo, Brazil, within Sao Paulo Federal University. 

 Looking back over the last 20 years, what have been the highlights for you?
In the late 1990s, we created a strong partnership with Sao Paulo Federal University through which we trained hundred of undergraduate students and residents, as well as 260 post-graduate students (masters, PhD and post-doc) in the principles of evidence-based health care and systematic reviews. The work of Cochrane Brazil led to the creation of the first post-graduate course in in the country and the first undergraduate course in evidence-based health care for medical students in Brazil. 

In 2003 our team started to train strategic technical officers of the Brazilian Ministry of Health. This initiative resulted in savings of approximately 5 to 10 billion dollars per year in the budget of the public health system in Brazil. In 2011, thanks to this continued work, the President of Brazil created a federal law (number 12401) which mandated the use of high-quality health technology assessments, using Cochrane Reviews as the gold standard in health research, to incorporate any new technology in the national health system.

We have produced more than 300 Cochrane Reviews. Three of the team members of Cochrane Brazil rank among the top 10 authors who have produced the largest numbers of publications in the area in the country. 

We have invested in the dissemination of the “culture of evidence-based health care” all over the country, using distance courses and approximately 1500 TV programs broadcast in open channels prime time with the support of important partners like the Sao Paulo Medical Association. These initiatives continue up to this date.
In 2007, the president of Brazil (Lula), along with several ministers and authorities, visited Sao Paulo Federal University to launch a national family program and to acknowledge and recognize the work of the Brazilian Cochrane Center in the country. 

In 2007 we held the XV Cochrane Colloquium in Sao Paulo, with approximately 1000 participants. Alongside the intense scientific program, the social activities of this Colloquium were very successful and created new friendships. The activities included a soccer match between Cochrane participants and famous (retired) Brazilian players (such as Socrates, Rivelino, Ademir da Guia, Raí, Edu and many others), as well as samba classes. The farewell party of this Colloquium was one of the most popular ever!

In 2013, thanks to our work within the Education and Health Ministries, we helped to create an evidence-based health care site with thousands of evidence syntheses and health technology assessments freely available to all Brazilian healthcare professionals.

 Why are these the most important to you?
At the beginning, we faced a strong resistance in relation to EBHC and the relevance of the Brazilian Cochrane Center by many investigators, institutions, and university professors. Over time, we managed to overcome these barriers and obtain the recognition and even endorsement of universities, professional associations, and the Ministry of Health for our work. Recently, we have also gained the respect of regional and Supreme Court judges and journalists for our work. 

What are the priorities for you and Cochrane Brazil in the forseeable future?
We want to keep on investing in developing and expanding the culture of evidence-based health care - not only in the health field, but also in other areas such including law, journalists, librarians, and consumers in general. We are also developing a network of Affiliate Centers within the country, as part of the first national Cochrane Network.

How are you celebrating the 20th anniversary?
We are preparing a celebration ceremony that will include awards to all those who have helped us over the years such as Health Ministers, Deans, Co-ordinators of the post-graduate courses, colleagues who helped us to found and run the Center, authorities of the Brazilian legal system, and national and international pioneers of the Cochrane Collaboration.

What’s your message to health decision makers in Brazil at this special time for Cochrane Brazil?
We are very happy with the progress that health decision makers have made over the years in Brazil and for their continued support for our work. We hope that they will continue to endorse our work and help to disseminate the concepts of evidence-based health care to the new generation.



Cochrane Brazil celebrate their 20th Anniversary on 31st October 2016.

Visit the Cochrane Brazil website

Monday, October 24, 2016

Featured Review: Nasal decongestants in monotherapy for the common cold

Fri, 10/21/2016 - 18:26

Do nasal decongestants used alone relieve cold symptoms?

Colds, although not serious, are common illnesses responsible for many visits to family doctors and days lost from work and school. Cold symptoms may last up to two week and include runny nose, sore throat, and sneezing. There is no cure for colds; treatments only ease the symptoms. Many people use over-the-counter medicines such as nasal decongestants to treat cold symptoms.

A team of Cochrane authors based in Australia and Belgium worked with Cochrane Acute Respiratory Infections to investigate if nasal decongestants help ease congestion caused by colds. 15 trials with 1,838 participants were included; 14 included only adults aged 18 years or over. Six studies used a single-dose nasal decongestant and measured the effects on the day it was administered. Nine studies used multiple doses and the effects were measured between one and 10 days after first administration. Eleven studies used tablets or syrup and four studies used nasal sprays. Nine studies were funded by drug manufacturers or agencies with commercial interests in the study results. Funding sources were unclear in six studies. The quality of evidence was assessed to be low.

The Cochrane Review was unable to draw conclusions about single-dose nasal decongestants. There was a small benefit in the relief of nasal congestion from multiple doses, but it was unclear if this was beneficial for patients. No studies reported overall patient well-being. There was no difference in the numbers of adverse events between people who used a nasal decongestant and those who did not. It was not possible to determine if there was a difference in effects between decongestant tablets and nasal sprays. The results relate to adults; there was no evidence on the effectiveness or safety of nasal decongestants for children.

“Nasal decongestants, available as tablets, nasal sprays, or drops, are available over-the-counter without restrictions. Given how uncomfortable cold symptoms can be, many turn to nasal decongestants but just how effective and safe they are was unclear,“ says Dr. Laura Deckx  from The University of Queensland and lead author of the Cochrane Review. “Given the high consumption of nasal decongestants it was surprising that so little evidence is available. Based on the current limited evidence, we were unable to draw conclusions if using just nasal decongestants was effective and safe for adults – this is something consumers should consider when at the drug store looking to relieve their common cold symptoms.”

Read the full Cochrane Review
Visit the Cochrane Acute Respiratory Infections website

Wednesday, October 26, 2016

What is Cochrane?

Thu, 10/20/2016 - 16:11

Cochrane exists so that healthcare decisions get better.

Cochrane is a global independent network of researchers, professionals, patients, carers, and people interested in health. Many of our contributors are world leaders in their fields - medicine, health policy, research methodology, or consumer advocacy - and our groups are situated in some of the world's most respected academic and medical institutions.

Cochrane contributors - 37,000 from more than 130 countries - work together to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest. We gather and analyze the  best available evidence to help people make informed decisions about health and health care.

We do not accept commercial or conflicted funding. This is vital for us to generate authoritative and reliable information, working freely, unconstrained by commercial and financial interests. Our work is recognized as representing an international gold standard for high quality, trusted information.


The need for Cochrane's work is even greater than it was when we started 20 years ago. As access to health evidence increases, so do the risks of misinterpreting complex content; meanwhile the likelihood of any one person getting a complete and balanced picture decreases. Our mission to provide accessible, credible information to support informed decision-making has never been more important or useful for improving global health.

Thursday, October 20, 2016

Cochrane seeks Java Developer - Western Europe location

Thu, 10/20/2016 - 13:35

Specifications: Full Time, permanent position
Location: any Western Europe location considered, Copenhagen, Denmark or Freiburg, Germany, preferred
Application Closing Date: 18 November 2016

This is a challenging and interesting opportunity for an experienced developer to contribute to a non-profit organisation with a social mission to improve health care for everyone.

Job description: You will be based in Cochrane’s Informatics and Knowledge Management Team, and you will have primary responsibility for web services for Cochrane systematic review production software. These web services are central to Cochrane’s new review production ecosystem, linking several applications from Cochrane and partners.

Requirements: The job requires experience with web service technologies (particularly RESTful APIs), Java EE (JMS, EJB, JPA, JTA), SQL databases, XML, and JSON. We also expect you to have experience with automated testing, and help us improve our test infrastructure and processes. We are looking for a thorough, organised and collaborative team member who will contribute to good practice standards and strive for quality.

About Cochrane: Cochrane is a global independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making the vast amounts of evidence generated through research useful for informing decisions about health. We do this by identifying, appraising and synthesizing individual research findings to produce the best available evidence on what can work, what might harm and where more research is needed.

Our work is recognised as the international gold standard for high quality, trusted information. We want to be the leading advocate for evidence-informed health care across the world.  

Applying: If you would like to apply for this position, please send a CV along with a supporting statement to recruitment@cochrane.org with “Systems Developer” in the subject line.  The supporting statement should indicate why you are applying for the post, and how far you meet the requirements for the post outlined in the job description using specific examples.  List your experience, achievements, knowledge, personal qualities and skills which you feel are relevant to the post.

For further information, please see the full job description or contact Gert van Valkenhoef, gvanvalkenhoef@cochrane.org, IT Development Manager.

Thursday, October 20, 2016 Category: Jobs

Cochrane seeks Web Application Developer - Western Europe location

Thu, 10/20/2016 - 13:15

Specifications: Full Time. Contract until 27 December 2017
Location: any Western Europe location considered, Copenhagen, Denmark or Freiburg, Germany, preferred
Application Closing Date: 18 November

This is a challenging and interesting opportunity for a front-end developer to contribute to a non-profit organisation with a social mission to improve health care for everyone.

Job description: You will be based in Cochrane’s Informatics and Knowledge Management Team, and you will have key responsibility for our browser based review writing software: a modern web application being built on AngularJS, and the centre piece to Cochrane’s new review production ecosystem.

Requirements: We are looking for a solution-focused individual with experience developing front-end web applications in JavaScript using AngularJS or similar frameworks. Experience developing performant cross-browser and cross-device applications using responsive design is strongly preferred. Our ideal candidate also has experience in unit-testing front-end code and is aware of user experience best practices.

About Cochrane: Cochrane is a global independent network of health practitioners, researchers, patient advocates and others, responding to the challenge of making the vast amounts of evidence generated through research useful for informing decisions about health. We do this by identifying, appraising and synthesizing individual research findings to produce the best available evidence on what can work, what might harm and where more research is needed.

Our work is recognised as the international gold standard for high quality, trusted information. We want to be the leading advocate for evidence-informed health care across the world.  

Applying: If you would like to apply for this position, please send a CV along with a supporting statement to recruitment@cochrane.org with “Web Applications Developer” in the subject line.  The supporting statement should indicate why you are applying for the post, and how far you meet the requirements for the post outlined in the job description using specific examples.  List your experience, achievements, knowledge, personal qualities and skills which you feel are relevant to the post.

For further information, please see the full job description, or contact Gert van Valkenhoef, gvanvalkenhoef@cochrane.org, IT Development Manager.

Thursday, October 20, 2016 Category: Jobs

Seoul Colloquium news

Wed, 10/19/2016 - 04:00

Cochrane Colloquia are our annual flagship events, bringing together Cochrane contributors from around the world to discuss, develop and promote Cochrane, and help shape its future.

The 2016 Cochrane Colloquium will be held in Seoul, South Korea from 23-27 October. For full information regarding the Colloquium, please visit the website.

  • Key information
  • Latest news
  • Plenaries, speakers and symposia
Key information:Latest news:
  • The Colloquium app is now available!
    The app is available to download for free, for both Android and iOS (iPhone and iPad).

    To access the app, search for “Cochrane Colloquium” in either the Google Play Store or the Apple App Store.

    Please note that there are other, seemingly related apps available – neither is relevant to the Seoul Colloquium!

    1. “Cochrane Colloquium 2015”, the app for last year’s Colloquium, is still available on both platforms.

    2. “Cochrane UK & Ireland”, the app for the 2016 Cochrane UK & Ireland Symposium, is also still available on the Google Play Store.

     

  • Sign-up for the Anne Anderson Walk
    The walk around Gyeongbokgung (Gyoengbok Palace) is a fundraising event for the Anne Anderson Award fund. The walk is on Wednesday 26 October at 14:30. The tour guides have been provided gratis. If you would like to sign-up for the walk, you can do so here. To donate to the award fund, click here.

  • 2016 Annual General Meeting
    Cochrane’s Annual General Meeting will be held on Tuesday 25 October, at the Colloquium. Find out more, here.

  • Sign-up now open for the full Colloquium schedule
    Sign-up for all the sessions you want to attend and create your own personal schedule for the Colloquium! You can also export the schedule to your online calendar. Download the Colloquium app to sync with your personal schedule. Details of the poster sessions are being finalized now and will be available from 21 September. 

  • Very limited room availability at the Grand Hilton
    As of 25 August, we have been advised that very few rooms are available. We have removed the online reservation page - please contact the Hilton directly (via reservation.grandseoul@hilton.com 
     or T +82-2-2287-8428) to check if there are any rooms available.
Plenary 1: Overdiagnosis and overtreatment in health care

In this session, the role of evidence-based health care and systematic reviews in limiting overdiagnosis and oversue will be discussed, including realignment of disease definition; quantification and monitoring of overdiagnosis; sensitisation of health professionals and patients; provision of balanced information on risk and benefits intervention; and the implications for Cochrane.

Speakers:

  • Alexandra Barratt, Professor of Public Health, School of Public Health, University of Sydney

  • Rita F. Redberg, Editor, JAMA Internal Medicine. Professor of Medicine, Division of Cardiology, University of California, San Francisco

  • Jenny Doust, Professor of Public Health, Faculty of Health Sciences and Medicine, Bond University

Plenary 2: Challenges and different approaches to improve the quality, timeliness and usability of Cochrane Reviews

The speakers in the plenary session have been asked to describe their experiences in making challenging decisions regarding the quality and usability of Cochrane reviews. Different perspectives and lively debate will be sought with particular focus on potential initiatives that are being explored and are consistent with the CEU vision for high quality and timely Cochrane Reviews that meets the needs of end-users and informs clinical care and health policy.

Speakers:

  • James Thomas, Project Transform, Cochrane. Director of the EPPI-Centre’s Reviews Facility, Department of Health, England

  • Karla Soares-Weiser, Deputy Editor in Chief, Cochrane Library & Cochrane Innovations

  • Marguerite Koster, External Member, Cochrane Steering Group

  • Harriet MacLehose, Senior Editor, Cochrane Library

  • Claire Glenton, Director, Cochrane Norway

Plenary 3: Data transparency: where are we and what can we get?

Pressure to increase transparency of data in clinical research is growing as scientific academies, regulatory agencies, funders and international organisations join the call for more data transparency. In this session, recent issues in the open data movement, data access policies and its impact on health care are discussed. Some examples of the impact of lack of transparency in East Asia will highlighted.

Speakers:

  • Kay Dickersin, Director, Cochrane United States. Director, Johns Hopkins Center for Clinical Trials & Evidence Synthesis

  • Byung Joo Park, Professor, Department of Preventive Medicine, Seoul National University College of Medicine

  • Lesley Stewart, Director, Centre for Reviews and Dissemination, University of York

  • Rintaro Mori, Director, Cochrane Japan. Head of Department National Center for Child Health and Department of Clinical Epidemiology

Annual Cochrane Lecture: Four challenges for EBM and Cochrane’s future

Since the term evidence based medicine (EBM) was coined over 20 years ago it has had a remarkable global influence. But EBM is not a static set of concepts, set in stone tablets in the 1990s; it is a young and evolving discipline. The fundamental concept of systematic reviews – providing a periodic summary of all controlled trials to aid clinical care – may have changed little since the birth of Cochrane. However, how to best provide and apply these in practice continues to develop.

In this year’s Cochrane Lecture, Paul Glasziou will propose four areas requiring renewed or ongoing attention:

  1. Improve dialogue between “evidologists” and clinicians
  2. Treatment is the patient’s decision: support and promote shared decision making
  3. Take non-drug interventions as seriously as pharmaceuticals
  4. Sustain investment in automating evidence synthesis 

Speaker:

  • Paul Glasziou, Professor, Evidence-Based Medicine at Bond University; Chair, International Society for Evidence-Based Health Care

#CochraneTech Symposium: The new ecosystem for evidence synthesis

Cochrane’s technological innovations are set to transform the way evidence for health is created and used. Join us at the #CochraneTech Symposium in Seoul to discover first-hand the emerging Cochrane ecosystem for evidence synthesis.

We’re preparing an exciting morning of talks and discussion centred around how Cochrane is using its technology to help both prepare systematic reviews more efficiently but also better deliver outputs to our end-users. The #CochraneTech Symposium is the premier event for those interested in the application and integration of existing and emerging technologies in the production of Cochrane systematic reviews and evidence synthesis in health care.

Since the inaugural #CochraneTech Symposium in Québec City in 2013 several ambitious technological strategies have been pursued by Cochrane, and we welcome you to join us in exploring this new ecosystem for evidence synthesis.

Methods Symposium: Living Systematic Reviews: Methods, Opportunities and Challenges

Living systematic reviews, as online summaries of healthcare research that are updated as new research becomes available, offer exciting possibilities in the new evidence ecosystem. Momentum is building around the living systematic review concept: a number of approaches are being piloted and Cochrane is at the forefront of these efforts. Living systematic reviews differ from traditional systematic reviews in several ways that have important implications for review methods and processes, affecting authors, editors and publishers. 

At this interactive symposium, we will explore what living systematic reviews actually are and their implications for Cochrane. Participants will hear from those who have been piloting living systematic review methods and will be invited to contribute their expertise as we explore the implications of LSRs for review methods and review production processes, plus the enablers within Cochrane to support their introduction.

Knowledge Translation (KT) Symposium

In 2016 Cochrane is embarking on the development of a Knowledge Translation (KT) Strategy, which will inform, facilitate and coordinate KT activities within Cochrane. We hope this strategy will scope knowledge translation activities for Cochrane, build on the Strategy to 2020 goals and provide a framework and co-ordination to support those who are undertaking knowledge translation activities in Cochrane. This framework will guide our knowledge translation work and ensure quality of outputs. We hope to establish mechanisms for better coordination of knowledge translation work within Cochrane so that organisational learning in this area flows through Cochrane.

In this symposium we will be presenting the current draft of Cochrane’s KT strategy. There will be brief presentations on the work around the strategy, an opportunity for discussion and input into further development of the strategy and the implementation plans accompanying it and what it will mean for knowledge translation in Cochrane.

Look forward to seeing you in Seoul in October!

Wednesday, October 19, 2016

Cochrane seeks members for its inaugural Scientific Committee

Tue, 10/18/2016 - 18:42

Cochrane is looking for skilled and experienced methodologists, researchers, and editors to form a Scientific Committee - an independent forum providing guidance to the Editor in Chief to ensure that Cochrane Reviews always represent the best methodological practice in evidence synthesis.

Cochrane Reviews are used to inform healthcare and health policy internationally. It is therefore imperative that they consistently and reliably use the most appropriate and scientifically validated methods. In the fast-moving field of evidence synthesis, Cochrane needs to identify and assess new methods and related developments, such as the rise in the use of technology to perform core tasks. The Scientific Committee will receive the support of the Cochrane Library Editor in Chief, along with other Cochrane Groups and committees.

For further information on the role of the Scientific Committee and membership criteria, please see the application form. Deadline for applications is Friday 25th November 2016. A selection panel with both Cochrane and non-Cochrane members will choose the most appropriate people and create a balanced Committee structure to fulfil its remit.  

For further information or informal enquiries please contact Jackie Chandler (Methods Co-ordinator) jchandler@cochrane.org

Tuesday, November 22, 2016 Category: Jobs

Apply for the Cochrane-REWARD prize for reducing waste in research

Fri, 10/14/2016 - 17:34

The 2009 Lancet paper on adding value and reducing waste in research has documented that much research is wasted because its outcomes cannot be used [1]. The waste occurs during 5 stages of research production: question selection, study design, research conduct, publication, and reporting [2,3]. For each of design, publication, and reporting there is a "loss" of around 50%, which implies a total waste of at least 85%. This translates into an estimated global loss of around $170 billion per year. Much of this waste appears to be avoidable or remediable, but there is little recognition of the need to develop and implement the needed remedies.

The Cochrane-REWARD prize will highlight both underused "remedies" and the need to invest in research to identify problems and solutions to them. Cochrane is now calling for nominations for the 2017 prize  - submissions close 28 February 2017

More information on the prize and how to submit a nomination

  1. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009 Jul 4;374(9683):86-9.
  2. Macleod MR, Michie S, Roberts I, et al. Biomedical research: increasing value, reducing waste. Lancet. 2014 Jan 11;383(9912):101-4.
  3. Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014 Jan 18;383(9913):267-76.
Tuesday, January 10, 2017

The Cochrane Library - iPad edition

Fri, 10/14/2016 - 04:00

The Cochrane Library iPad edition presents the latest up-to-date evidence from the Cochrane Library in a convenient, easy to navigate format which provides you with relevant, accessible research, when you need it, from the world’s leading experts in evidence-informed health care.



Our monthly issues feature a hand-picked selection of Cochrane Systematic Reviews, specifically abridged to provide the best possible iPad reading experience. The themed sections in every issue are colour-coded throughout so that you can easily find content relevant to you. The Bookmark feature allows you to create your own special collection of Cochrane Reviews across issues. Additionally, the title page for every review includes a link to the full version of the review available on the Cochrane Library at www.cochranelibrary.com.

All content in the app is free, and new issues will download regularly to your Newsstand.

Download the app from iTunes, or contact CochraneApp@wiley.com to receive iPad edition announcements via e-mail or for technical support.

Friday, November 18, 2016

Cochrane in the news: October 2016

Tue, 10/04/2016 - 19:04

A round-up of selected recent coverage citing, discussing, and presenting health evidence - updated throughout the month.

 

 

Andrew Moore, author and editor for the Cochrane Pain, Palliative, and Supportive care group, looks at the safety and effectiveness of Paracetamol in The Conversation.

News-Medical.Net featured an interview with Cochrane Reviewer and discusses the Cochrane approach to evidence and recent evidence on Vitamin D for asthma attacks.

Cochrane contributor Hilda Bastian blogs on PLoS in memory of longtime Cochrane contributor Andrew Herxheimer and shares the untold story of his father, Herbert Herxheimer.


En route
, Air Canada’s in-flight magazine, spotlight frequent flyer Peter Tugwell, Coordinating Editor of Cochrane Musculoskeletal.


Sexually Transmitted Infections BMJ blog
post focuses on recent Cochrane Review on chlamydia.


Professor Edzard Ernst draws on Cochrane Evidence in his post on homeopathy in his post in Spector Health.

 

Article on the Vox looks at project aimed at building a foundation of critical thinking skills about health in schools.

Monday, October 31, 2016

Monash University seeks Research Fellow (Evidence Review) - Melbourne, Australia

Fri, 09/23/2016 - 03:22

Monash University Mental Health and General Practice is seeking a Research Fellow (Evidence Review)

Closing date: 22 November

Job No: 552703
Faculty/Portfolio:
Faculty of Medicine, Nursing and Health Sciences
School of Primary Health Care
Department of General Practice
Location: Notting Hill
Employment Type: Part-time (0.8)
Duration: 12 month fixed-term appointment
Remuneration:
Pro-rata of $62,271 - $84,513 pa Level A PhD
(plus 9.5% employer superannuation)

For complete information on the position and how to apply, please see the full posting on the Monash website.

Tuesday, November 22, 2016 Category: Jobs

Translated Cochrane evidence

Fri, 09/16/2016 - 04:00

Bringing you Cochrane evidence in 13 different languages
 
Making Cochrane evidence accessible to non-English speakers is a priority for us. More than 4,000 translations of Cochrane Review plain language summaries/abstracts have been published so far this year. Translation activities are led by local Cochrane groups and their translator communities, the majority of which are volunteer based. Due to the length of Cochrane Reviews, our teams focus on the abstract and or the Plain Language Summary.
 
Find Cochrane evidence in different languages: Cochrane evidence is currently translated into 13 languages: Croatian, French, German, Japanese, Korean, Malay, Polish, Portuguese, Russian, Simplified Chinese, Spanish, Tamil and Traditional Chinese. Each language has its own version of cochrane.org; you can view translations by clicking on the languages that appear across the top of each page.

Cochrane Podcasts in different language: Cochrane podcasts offer a short summary of a recent Cochrane review and have been recorded in 33 languages.
 
Most translated Reviews: The links below will take you to the English language version of our most translated Reviews. Languages these Reviews have been translated into are listed across the top of the page. To read the Review in another language, simply click on the language and it will take you to the translation.
· Interventions for preventing obesity in children
· Electronic cigarettes for smoking cessation and reduction
· Vitamin C for preventing and treating the common cold
· Continuous support for women during childbirth
 
Our translation achievements for the first half of 2016 in an infographic:

Monday, November 21, 2016

Pages